Skip to main content

Table 3 ORR, DCR, mPFS, mOS and adverse reactions of apatinib in the treatment of osteosarcoma

From: Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients

  1. ORR (exclude): One study with effective value is 0 is excluded
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us